{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:40:17Z","timestamp":1767148817675,"version":"build-2238731810"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["19K07952"],"award-info":[{"award-number":["19K07952"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22K07927"],"award-info":[{"award-number":["22K07927"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["21ae0201004h0004"],"award-info":[{"award-number":["21ae0201004h0004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22ae0201004h0005"],"award-info":[{"award-number":["22ae0201004h0005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ymgmr.2023.101021","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T12:16:27Z","timestamp":1699704987000},"page":"101021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Enhanced osteoblastic differentiation of parietal bone in a novel murine model of mucopolysaccharidosis type II"],"prefix":"10.1016","volume":"37","author":[{"given":"Narutoshi","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ohtake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahito","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torayuki","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Mashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2023.101021_bb0005","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0010","series-title":"Metab. Mol. Bases Inherit. Dis","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgmr.2023.101021_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2016.05.003","article-title":"Molecular diagnosis of 65 families with mucopolysaccharidosis type II (hunter syndrome) characterized by 16 novel mutations in the IDS gene: genetic, pathological, and structural studies on iduronate-2-sulfatase","volume":"118","author":"Kosuga","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ymgme.2012.12.010","article-title":"Effects of idursulfase enzyme replacement therapy for Mucopolysaccharidosis type II when started in early infancy: comparison in two siblings","volume":"108","author":"Tajima","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-02052-4","article-title":"Evaluation of the long-term treatment effects of intravenous idursulfase in patients with mucopolysaccharidosis II (MPS II) using statistical modeling: data from the hunter outcome survey (HOS)","volume":"16","author":"Muenzer","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0030","series-title":"Criteria Required to Make a Confirmatory Diagnosis, Diagnostics (Basel, Switzerland)","article-title":"Nationwide newborn screening program for Mucopolysaccharidoses in Taiwan and an update of the \u201cgold standard\u201d","volume":"vol. 11","author":"Chuang","year":"2021"},{"key":"10.1016\/j.ymgmr.2023.101021_bb0035","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s10545-018-0221-0","article-title":"The efficacy of intracerebroventricular idursulfase-beta enzyme replacement therapy in mucopolysaccharidosis II murine model: heparan sulfate in cerebrospinal fluid as a clinical biomarker of neuropathology","volume":"41","author":"Sohn","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.omtm.2021.02.018","article-title":"Impact of intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II","volume":"21","author":"Seo","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymthe.2018.12.005","article-title":"Iduronate-2-sulfatase with anti-human transferrin receptor antibody for neuropathic Mucopolysaccharidosis II: a phase 1\/2 trial","volume":"27","author":"Okuyama","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0050","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2020.09.039","article-title":"A phase 2\/3 trial of Pabinafusp alfa, IDS fused with anti-human transferrin receptor antibody, targeting neurodegeneration in MPS-II","volume":"29","author":"Okuyama","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0055","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.ymthe.2021.03.019","article-title":"Iduronate-2-sulfatase fused with anti-hTfR antibody, pabinafusp alfa, for MPS-II: a phase 2 trial in Brazil","volume":"29","author":"Giugliani","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1163","article-title":"Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice","volume":"12","author":"Ullman","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0065","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145445","article-title":"Iduronate-2-sulfatase transport vehicle rescues behavioral and skeletal phenotypes in a mouse model of hunter syndrome","volume":"6","author":"Arguello","year":"2021","journal-title":"JCI Insight."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/dvg.23248","article-title":"A tale of two cities: the genetic mechanisms governing calvarial bone development","volume":"57","author":"Ferguson","year":"2019","journal-title":"Genesis."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0075","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/dvdy.278","article-title":"Making and shaping endochondral and intramembranous bones","volume":"250","author":"Galea","year":"2021","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0080","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ymgme.2009.03.005","article-title":"Mechanism of shortened bones in mucopolysaccharidosis VII","volume":"97","author":"Metcalf","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0085","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s10545-007-0641-8","article-title":"The characterization of a murine model of mucopolysaccharidosis II (hunter syndrome)","volume":"30","author":"Garcia","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ymgme.2012.05.005","article-title":"Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II","volume":"107","author":"Higuchi","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0095","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ymthe.2018.02.032","article-title":"A blood-brain-barrier-penetrating anti-human transferrin receptor antibody fusion protein for Neuronopathic Mucopolysaccharidosis II","volume":"26","author":"Sonoda","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ajhg.2009.07.011","article-title":"IDS crossing of the blood-brain barrier corrects CNS defects in MPSII mice","volume":"85","author":"Polito","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0105","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/hmg\/ddl038","article-title":"Correction of hunter syndrome in the MPSII mouse model by AAV2\/8-mediated gene delivery","volume":"15","author":"Cardone","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10059-010-0083-2","article-title":"Characterization of a novel mucopolysaccharidosis type II mouse model and recombinant AAV2\/8 vector-mediated gene therapy","volume":"30","author":"Jung","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymgmr.2023.101021_bb0115","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1089\/hum.2016.184","article-title":"Prevention of neurocognitive deficiency in Mucopolysaccharidosis type II mice by central nervous system-directed, AAV9-mediated Iduronate sulfatase gene transfer","volume":"28","author":"Laoharawee","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0120","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86696","article-title":"CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (hunter syndrome)","volume":"1","author":"Motas","year":"2016","journal-title":"JCI Insight."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.omtm.2020.09.012","article-title":"Ex vivo gene therapy treats bone complications of Mucopolysaccharidosis Type II mouse models through bone remodeling reactivation","volume":"19","author":"Wada","year":"2020","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0130","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1038\/srep05396","article-title":"Rapid generation of mouse models with defined point mutations by the CRISPR\/Cas9 system","volume":"4","author":"Inui","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-34541-w","article-title":"A novel mucopolysaccharidosis type II mouse model with an iduronate-2-sulfatase-P88L mutation","volume":"13","author":"Mashima","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0140","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/labinvest.2010.121","article-title":"Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive histiocytic sarcoma","volume":"90","author":"Mashima","year":"2010","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ymgmr.2018.08.005","article-title":"Quantification of 11 enzyme activities of lysosomal storage disorders using liquid chromatography-tandem mass spectrometry","volume":"17","author":"Ohira","year":"2018","journal-title":"Mol. Genet. Metab. Reports."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0150","article-title":"Enhanced activation of canonical Wnt signaling confers mesoderm-derived parietal bone with similar osteogenic and skeletal healing capacity to neural crest-derived frontal bone","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2023.101021_bb0165","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/gtc.12894","article-title":"Production of therapeutic iduronate-2-sulfatase enzyme with a novel single-stranded RNA virus vector","volume":"26","author":"Ohira","year":"2021","journal-title":"Genes Cells"},{"key":"10.1016\/j.ymgmr.2023.101021_bb0170","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ymgme.2016.01.009","article-title":"The natural history of growth in patients with hunter syndrome: data from the hunter outcome survey (HOS)","volume":"117","author":"Parini","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1651-2227.2007.00212.x","article-title":"A clinical study of 77 patients with mucopolysaccharidosis type II","volume":"96","author":"Schwartz","year":"2007","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0180","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1651-2227.2010.02060.x","article-title":"Growth pattern and growth prediction of body height in children with mucopolysaccharidosis type II","volume":"100","author":"Rozdzynska","year":"2011","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0185","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/GIM.0b013e31817701e6","article-title":"Initial report from the hunter outcome survey","volume":"10","author":"Wraith","year":"2008","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0190","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1359\/jbmr.091116","article-title":"Origin matters: differences in embryonic tissue origin and Wnt signaling determine the osteogenic potential and healing capacity of frontal and parietal calvarial bones","volume":"25","author":"Quarto","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014033","article-title":"Activation of FGF signaling mediates proliferative and osteogenic differences between neural crest derived frontal and mesoderm parietal derived bone","volume":"5","author":"Li","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2023.101021_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/jdb9030023","article-title":"Wnt-dependent activation of ERK mediates repression of chondrocyte fate during Calvarial development","volume":"9","author":"Ibarra","year":"2021","journal-title":"J. Dev. Biol."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0205","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103087118","article-title":"Spatial transcriptomics reveals a role for sensory nerves in preserving cranial suture patency through modulation of BMP\/TGF-\u03b2 signaling","volume":"118","author":"Tower","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0210","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000202789","article-title":"Differential FGF ligands and FGF receptors expression pattern in frontal and parietal calvarial bones","volume":"190","author":"Quarto","year":"2009","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.ymgmr.2023.101021_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-81434-x","article-title":"Dlx5-augmentation in neural crest cells reveals early development and differentiation potential of mouse apical head mesenchyme","volume":"11","author":"Vu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0220","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s11914-020-00603-5","article-title":"Polycomb repressive complex 2: a dimmer switch of gene regulation in Calvarial bone development","volume":"18","author":"Nehila","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-24917-9","article-title":"The developing mouse coronal suture at single-cell resolution","volume":"12","author":"Farmer","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymgmr.2023.101021_bb0230","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/jbmr.3563","article-title":"The lysosomal protein arylsulfatase B is a key enzyme involved in skeletal turnover","volume":"33","author":"Pohl","year":"2018","journal-title":"J. Bone Miner. Res."}],"updated-by":[{"DOI":"10.1016\/j.ymgmr.2024.101098","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000}}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426923000678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T21:17:18Z","timestamp":1734556638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426923000678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":44,"alternative-id":["S2214426923000678"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.101021","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced osteoblastic differentiation of parietal bone in a novel murine model of mucopolysaccharidosis type II","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2023.101021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101021"}}